{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:59:18Z","timestamp":1787021958744,"version":"build-2736575974"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T00:00:00Z","timestamp":1440115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0135937","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T13:59:06Z","timestamp":1440165546000},"page":"e0135937","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study"],"prefix":"10.1371","volume":"10","author":[{"given":"Peter A.","family":"Newman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Rubincam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Slack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaynab","family":"Essack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesan","family":"Chakrapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng-Min","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchon","family":"Tepjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Shunmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surachet","family":"Roungprakhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Logie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Koen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Lindegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,21]]},"reference":[{"key":"ref1"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1371\/journal.pmed.0020234","article-title":"The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?","volume":"2","author":"J Singh","year":"2005","journal-title":"PLoS Med"},{"key":"ref3","article-title":"New HIV Vaccine and Microbicide Advocacy Society (NHVMAS)","author":"M Ukpong"},{"key":"ref4","author":"E McGrory"},{"key":"ref5"},{"key":"ref6"},{"key":"ref7"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1371\/journal.pmed.0040273","article-title":"Grand challenges in global health: community engagement in research in developing countries","volume":"4","author":"P Tindana","year":"2007","journal-title":"PLoS Med"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-3156.2008.02207.x","article-title":"Community engagement in health research: two decades of experience from a research project on HIV in rural Uganda","volume":"14","author":"S Nakibinge","year":"2009","journal-title":"Trop Med Int Health"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1525\/jer.2013.8.4.1","article-title":"Consent and community engagement in diverse research contexts: reviewing and developing research and practice","volume":"8","year":"2013","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.socscimed.2008.02.007","article-title":"Beginning community engagement at a busy biomedical research programme: experiences from the KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya","volume":"67","author":"V Marsh","year":"2008","journal-title":"Soc Sci Med"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pt.2010.02.009","article-title":"Towards a framework for community engagement in global health research","volume":"26","author":"JV Lavery","year":"2010","journal-title":"Trends in Parasitol"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1586\/14760584.2014.953484","article-title":"Advancing community stakeholder engagement in biomedical HIV prevention trials: principles, practices and evidence","volume":"13","author":"PA Newman","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"Suppl 1","key":"ref14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/QAI.0000000000000032","article-title":"Implementation of HIV-related clinical research in the international setting","volume":"65","author":"C Godfrey","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9507","key":"ref15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0140-6736(06)68067-7","article-title":"Towards a science of community engagement","volume":"367","author":"PA Newman","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/erv.11.162","article-title":"Integrating social and biomedical science in HIV vaccine research: obstacles, opportunities and ways forward","volume":"11","author":"PA Newman","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"ref17","author":"RK Yin","year":"2012"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3102\/0013189X012002014","article-title":"Multisite qualitative policy research: optimizing description and generalizability","volume":"12","author":"RE Harriott","year":"1983","journal-title":"Educ Res"},{"key":"ref19","author":"SB Merriam","year":"1998"},{"key":"ref20","author":"RK Yin","year":"2014"},{"key":"ref21","first-page":"50","article-title":"Qualitative research in health care: assessing quality in qualitative research","volume":"320","author":"N Mays","year":"2000","journal-title":"Educ Debate"},{"issue":"23","key":"ref22","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Eng J Med"},{"key":"ref23","unstructured":"Namwat C, Morgan PA, Premsiri N, Debyasuvern T, Pitisuttithum P, Bussaratid V, et al. Social impact of participation in a phase III HIV vaccine trial in Thailand. Poster presented at: AIDS Vaccine; 2007 Aug 20\u201323; Seattle, WA."},{"issue":"44","key":"ref24","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1016\/j.vaccine.2014.08.043","article-title":"Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India","volume":"32","author":"PA Newman","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","article-title":"Safety and efficacy of the HVTN 503\/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept pase 2b study","volume":"11","author":"GE Gray","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"9653","key":"ref26","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/jis342","article-title":"Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)","volume":"206","author":"A Duerr","year":"2012","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJMoa0707957","article-title":"Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission","volume":"359","author":"L Van Damme","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1473-3099(07)70039-7","article-title":"Cellulose sulphate microbicide trial halted","volume":"7","author":"J Horwood","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"5996","key":"ref30","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Karim Q Abdool","year":"2010","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0140-6736(02)11079-8","article-title":"Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised, controlled trial","volume":"360","author":"L Van Damme","year":"2002","journal-title":"Lancet"},{"issue":"27","key":"ref32","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"RM Grant","year":"2010","journal-title":"N Engl J Med"},{"issue":"9883","key":"ref33","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"K Choopanya","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00002030-200301240-00003","article-title":"Candidate HIV\/AIDS vaccines: lessons learned from the World&apos;s first phase III efficacy trials","volume":"17","author":"DP Francis","year":"2003","journal-title":"AIDS"},{"key":"ref35","unstructured":"Fonsart J, Capitant C, Spire B, Cotte L, Pialoux G, Lorente N, et al. High adherence rate to intermittent oral PrEP with TDF\/FTC among high risk MSM (ANRS IPERGAY) [abstract]. 20th International AIDS Conference; 2014 Jul 20\u201325; Melbourne, Australia; TUAC0103."},{"key":"ref36"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1186\/1471-2458-13-731","article-title":"\u201cIf it\u2019s not working, why would they be testing it?\u201d: mental models of HIV vaccine trials and preventive misconception among men who have sex with men in India","volume":"13","author":"V Chakrapani","year":"2013","journal-title":"BMC Pub Health"},{"key":"ref38","unstructured":"UNAIDS. Thailand: HIV and AIDS estimates (2013). Published 2013 [cited 2015 Jun 15]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/en\/regionscountries\/countries\/thailand\" xlink:type=\"simple\">http:\/\/www.unaids.org\/en\/regionscountries\/countries\/thailand<\/ext-link>."},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.socscimed.2007.10.019","article-title":"Social impact of preventive HIV vaccine clinical trial participation: a model of prevention, assessment and intervention","volume":"66","author":"M Allen","year":"2008","journal-title":"Soc Sci Med"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.vaccine.2007.12.016","article-title":"Community heroes or \u201chigh-risk\u201d pariahs? Reasons for declining to enroll in an HIV vaccine trial","volume":"26","author":"PA Newman","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00126334-200008150-00010","article-title":"Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET vaccine preparedness study protocol team","volume":"24","author":"BA Koblin","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1521\/aeap.2006.18.6.560","article-title":"How should HIV vaccine efficacy trials be conducted? Diverse U.S. communities speak out","volume":"18","author":"SM Kegeles","year":"2006","journal-title":"AIDS Educ Prev"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.bdj.2008.292","article-title":"Analysing and presenting qualitative data","volume":"204","author":"P Burnard","year":"2008","journal-title":"Br Dent J"},{"key":"ref44","author":"KC Charmaz","year":"2006"},{"key":"ref45","author":"AL Strauss","year":"1998"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1207\/s15430421tip3903_2","article-title":"Determining validity in qualitative inquiry","volume":"39","author":"JW Creswell","year":"2000","journal-title":"Theory Pract"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/09540121.2012.656566","article-title":"Civil society perspectives on negative biomedical HIV prevention trial results and implications for future trials","volume":"24","author":"Z Essack","year":"2012","journal-title":"AIDS Care"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1471-8847.2012.00338.x","article-title":"\u201cIt looks like you just want them when things get rough\u201d: civil society perspectives on negative trial results and stakeholder engagement in HIV prevention trials","volume":"13","author":"J Koen","year":"2013","journal-title":"Dev World Bioeth"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.926","article-title":"Vaccine-induced HIV seropositivity\/reactivity in noninfected HIV vaccine recipients","volume":"304","author":"CJ Cooper","year":"2010","journal-title":"JAMA"},{"issue":"11","key":"ref50","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1371\/journal.pmed.0040324","article-title":"Clinical trials and medical care: defining the therapeutic misconception","volume":"4","author":"GE Henderson","year":"2007","journal-title":"PLoS Med"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jadohealth.2014.01.006","article-title":"Evaluation of an intervention among adolescents to reduce preventive misconception in HIV vaccine clinical trials","volume":"55","author":"M Lally","year":"2014","journal-title":"J Adolesc Health"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1556264615575509","article-title":"I\u2019m positive, but I\u2019m negative: competing voices in informed consent and implications for HIV vaccine trials","volume":"10","author":"C Rautenbach","year":"2015","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1353\/cpr.2012.0034","article-title":"Community-researcher partnership at NIAID HIV\/AIDS clinical trials sites: insights for evaluation and enhancement","volume":"6","author":"JM Kagan","year":"2012","journal-title":"Prog Community Health Partnersh"},{"key":"ref54","author":"Slevin K West"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"e100058","DOI":"10.1371\/journal.pone.0100058","article-title":"Improving ethical and participatory practice for marginalized populations in biomedical HIV prevention trials: lessons from Thailand","volume":"9","author":"D Allman","year":"2014","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/OAJCT.S45717","article-title":"Implementing good participatory practice guidelines in the FEM-PrEP preexposure prophylaxis trial for HIV prevention among African women: a focus on local stakeholder involvement","volume":"5","author":"N Mack","year":"2013","journal-title":"Open Access J Clin Trials"},{"issue":"4","key":"ref57","doi-asserted-by":"crossref","first-page":"e0003713","DOI":"10.1371\/journal.pntd.0003713","article-title":"What makes community engagement effective?: lessons from the Eliminate Dengue Program in Queensland, Australia","volume":"9","author":"PA. Kolopack","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 1","key":"ref58","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1478-4505-9-S1-S8","article-title":"Investing in the future: lessons learnt from communicating the results of HSV\/HIV intervention trials in South Africa","volume":"9","author":"S Delany-Moretlwe","year":"2011","journal-title":"Health Res Policy Syst"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1525\/jer.2010.5.2.3","article-title":"The exploitation of &quot;Exploitation&quot; in the tenofovir prep trial in Cameroon: lessons learned from media coverage of an HIV prevention trial","volume":"5","author":"N Mack","year":"2010","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"9","key":"ref60","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2105\/AJPH.2011.300208","article-title":"\u201cSpeaking the dialect\u201d: understanding public discourse in the aftermath of an HIV vaccine trial shutdown","volume":"101","author":"PA Newman","year":"2011","journal-title":"Am J Public Health"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/17441692.2010.549139","article-title":"HIV vaccine acceptability and culturally appropriate dissemination among sexually diverse Aboriginal peoples in Canada","volume":"7","author":"PA Newman","year":"2012","journal-title":"Glob Public Health"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12910-015-0033-9","article-title":"Evaluating community engagement in global health research: the need for metrics","volume":"16","author":"KM MacQueen","year":"2015","journal-title":"BMC Med Ethics"},{"key":"ref63","unstructured":"MacQueen KM, Harlan VS, West Slevin K, Hannah S, Bass E, Moffett J. 2012. Stakeholder engagement toolkit for HIV prevention trials. FHI 360. Published 2012 [cited 2015 Feb 12]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fhi360.org\/resource\/stakeholder-engagement-toolkit-hiv-prevention-trials\" xlink:type=\"simple\">http:\/\/www.fhi360.org\/resource\/stakeholder-engagement-toolkit-hiv-prevention-trials<\/ext-link>."},{"issue":"6","key":"ref64","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.socscimed.2007.10.022","article-title":"Defining the \u2018community\u2019 in community consultation for emergency research: findings from the community VOICES study","volume":"66","author":"DF Ragin","year":"2008","journal-title":"Soc Sci Med"},{"issue":"4","key":"ref65","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0277-9536(95)00439-4","article-title":"Meanings of community","volume":"43","author":"R Jewkes","year":"1996","journal-title":"Soc Sci Med"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12910-015-0014-z","article-title":"Community engagement strategies for genomic studies in Africa: a review of the literature","volume":"16","author":"P Tindana","year":"2015","journal-title":"BMC Med Ethics"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1472-6939-15-84","article-title":"Community engagement and the human infrastructure of global health research","volume":"15","author":"KF King","year":"2014","journal-title":"BMC Med Ethics"},{"key":"ref68","unstructured":"The Wellcome Trust. Community engagement\u2013under the microscope: international engagement workshop report. Wellcome Trust. Published June, 2011 [cited 2015 Jun 22]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.wellcome.ac.uk\/stellent\/groups\/corporatesite\/@msh_grants\/documents\/web_document\/wtvm054326.pdf\" xlink:type=\"simple\">http:\/\/www.wellcome.ac.uk\/stellent\/groups\/corporatesite\/@msh_grants\/documents\/web_document\/wtvm054326.pdf<\/ext-link>."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0135937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:52:14Z","timestamp":1540335134000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0135937"}},"subtitle":[],"editor":[{"given":"Vicki","family":"Marsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,21]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0135937","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,21]]}}}